Larry Goldstein to Coronary Disease
This is a "connection" page, showing publications Larry Goldstein has written about Coronary Disease.
Connection Strength
0.683
-
Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out. Cerebrovasc Dis. 2004; 18(1):1-2.
Score: 0.207
-
Neighborhood socioeconomic status and the prevalence of stroke and coronary heart disease in rural China: a population-based study. Int J Stroke. 2015 Apr; 10(3):388-95.
Score: 0.105
-
Statins after intracerebral hemorrhage: to treat or not to treat. Arch Neurol. 2011 May; 68(5):565-6.
Score: 0.082
-
Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2010 Mar; 41(3):426-30.
Score: 0.077
-
Impact of comorbidities on ischemic stroke outcomes in women. Stroke. 2008 Jul; 39(7):2138-40.
Score: 0.068
-
Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006 Feb; 37(2):577-617.
Score: 0.058
-
Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. J Stroke Cerebrovasc Dis. 2014 Apr; 23(4):778-84.
Score: 0.026
-
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008 Dec; 39(12):3297-302.
Score: 0.018
-
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology. 2009 Feb 24; 72(8):688-94.
Score: 0.017
-
Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology. 2004 Mar 23; 62(6):968-70.
Score: 0.013
-
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002 Jul 16; 106(3):388-91.
Score: 0.011